Abstract | BACKGROUND: In 2010 Singapore's National Health Survey reported 11.3% of the population between 18-69 years of age with diabetes, compared to 8.2% in 2006. This increasing trend reinforces the dependence on HbA(1c) for management of glycemic control. METHODS: To determine the incidence of hemoglobin variants received from our diabetic population who are attending the National University Hospital for testing of their HbA(1c) and determine whether the hemoglobin variant caused an interpretation issue, we reviewed all chromatograms from patients sending a sample for HbA(1c) analysis for a three-month period. Analysis was performed on the Variant II using the HbA(2)/HbA(1c) Dual program. RESULTS: CONCLUSIONS: Overall we obtained a prevalence of 2.3% of hemoglobin variants in our diabetic population being screened by HbA(1c) using Variant II.
|
Authors | Sharon Saw, Tze Ping Loh, Cecilia Yin, Sunil K Sethi |
Journal | Clinica chimica acta; international journal of clinical chemistry
(Clin Chim Acta)
Vol. 415
Pg. 173-5
(Jan 16 2013)
ISSN: 1873-3492 [Electronic] Netherlands |
PMID | 23117032
(Publication Type: Journal Article)
|
Copyright | Copyright © 2012 Elsevier B.V. All rights reserved. |
Chemical References |
|
Topics |
- Adolescent
- Adult
- Aged
- Diabetes Mellitus
(blood, diagnosis, ethnology, genetics)
- Female
- Glycated Hemoglobin
(analysis, genetics)
- Hemoglobinopathies
(blood, diagnosis, ethnology, genetics)
- Homozygote
- Humans
- Male
- Middle Aged
- Singapore
(epidemiology)
|